Columbia University Medical Center, Herbert Irving Comprehensive Cancer Center

New York, New York 10032

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma, Hepatocellular Carcinoma, Leukemia, Myeloid, Acute, Metastatic Melanoma, Myelodysplastic Syndromes, Non Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Shared Neoantigen-Positive Solid Tumors

Studies at this site

• A Long-term Follow-up Study of Patients Who Received VOR33 — Stopped early
• Allogeneic Engineered Hematopoietic Stem Cell Transplant (HCT) Lacking the CD33 Protein, and Post-HCT Treatment With Mylotarg, for Patients With CD33+ AML or MDS — Stopped early
• SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC) — Completed
• HD IL-2 + Ipilimumab in Patients With Metastatic Melanoma — Stopped early
• A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens — Completed
• Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer — Completed
• HD IL-2 + Vemurafenib in Patients With BRAF Mutation Positive Metastatic Melanoma — Stopped early
• A Study of Personalized Neoantigen Cancer Vaccines — Completed